Retirement Guys Formula’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Buy
187,062
+2,500
+1% +$7.61K 0.24% 95
2025
Q4
$768K Buy
184,562
+18,569
+11% +$97.8K 0.35% 99
2025
Q3
$703K Buy
165,993
+6,400
+4% +$24.1K 0.25% 107
2025
Q2
$337K Buy
159,593
+4,250
+3% +$6.36K 0.13% 110
2025
Q1
$190K Hold
155,343
0.09% 137
2024
Q4
$200K Buy
155,343
+91,526
+143% +$219K 0.1% 135
2024
Q3
$175K Buy
63,817
+22,660
+55% +$55.6K 0.08% 128
2024
Q2
$93K Buy
41,157
+7,425
+22% +$22.6K 0.04% 124
2024
Q1
$80.6K Buy
33,732
+12,232
+57% +$23.1K 0.04% 121
2023
Q4
$35.7K Buy
21,500
+10,000
+87% +$19.4K 0.02% 125
2023
Q3
$22.1K Buy
+11,500
New +$18.9K 0.02% 120

Other funds holding GALT